420 related articles for article (PubMed ID: 33241658)
1. Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.
Qin X; Huang C; Wu K; Li Y; Liang X; Su M; Li R
J Cell Mol Med; 2021 Jan; 25(2):677-685. PubMed ID: 33241658
[TBL] [Abstract][Full Text] [Related]
2. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
[TBL] [Abstract][Full Text] [Related]
3. Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology.
Du HX; Zhu JQ; Chen J; Zhou HF; Yang JH; Wan HT
Aging (Albany NY); 2021 Jun; 13(11):14571-14589. PubMed ID: 34088885
[TBL] [Abstract][Full Text] [Related]
4. Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin.
Li Y; Yu S; Li Y; Liang X; Su M; Li R
Front Endocrinol (Lausanne); 2021; 12():714909. PubMed ID: 34712201
[TBL] [Abstract][Full Text] [Related]
5. Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection.
Liang W; Li X; Wang H; Nie K; Meng Q; He J; Zheng C
Front Immunol; 2022; 13():892350. PubMed ID: 35663983
[TBL] [Abstract][Full Text] [Related]
6. Virtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Coronavirus Infection.
Ping F; Wang Y; Shen X; Tan C; Zhu L; Xing W; Xu J
Med Sci Monit; 2022 Jan; 28():e934102. PubMed ID: 35075100
[TBL] [Abstract][Full Text] [Related]
7. Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.
Zheng WJ; Yan Q; Ni YS; Zhan SF; Yang LL; Zhuang HF; Liu XH; Jiang Y
BioData Min; 2020; 13():17. PubMed ID: 33082858
[TBL] [Abstract][Full Text] [Related]
8. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
Front Immunol; 2021; 12():769011. PubMed ID: 35069542
[TBL] [Abstract][Full Text] [Related]
9. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
11. Study on the mechanism of puerarin against osteoarthritis from ferroptosis based on network pharmacology and bioinformatics.
Deng W; Zhang W; He Q
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):959-968. PubMed ID: 37548663
[TBL] [Abstract][Full Text] [Related]
12. Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection.
Liang W; Li X; Yao Y; Meng Q; Wu X; Wang H; Xue J
Front Pharmacol; 2022; 13():921517. PubMed ID: 35677450
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation.
Zhuang Z; Zhong X; Zhang H; Chen H; Huang B; Lin D; Wen J
Comb Chem High Throughput Screen; 2021; 24(9):1377-1394. PubMed ID: 33135607
[TBL] [Abstract][Full Text] [Related]
14. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
15. Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach.
Lang W; Yang F; Cai F; Shi W; Dong M; An Q; Li Y
Comput Intell Neurosci; 2022; 2022():1493137. PubMed ID: 35855804
[TBL] [Abstract][Full Text] [Related]
16. Puerarin reduces ischemia/reperfusion-induced myocardial injury in diabetic rats via upregulation of vascular endothelial growth factor A/angiotensin-1 and suppression of apoptosis.
Guo BQ; Xu JB; Xiao M; Ding M; Duan LJ
Mol Med Rep; 2018 May; 17(5):7421-7427. PubMed ID: 29568939
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (
Wang L; Wang Y; Yang W; He X; Xu S; Liu X; He Y; Hu Q; Yuan D; Jin T
J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34313585
[No Abstract] [Full Text] [Related]
18. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
Xing Y; Hua YR; Shang J; Ge WH; Liao J
Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725
[TBL] [Abstract][Full Text] [Related]
19. Puerarin: A review of its mechanisms of action and clinical studies in ophthalmology.
Meng F; Guo B; Ma YQ; Li KW; Niu FJ
Phytomedicine; 2022 Dec; 107():154465. PubMed ID: 36166943
[TBL] [Abstract][Full Text] [Related]
20. The mechanism and active compounds of semen
Wang Y; Gu W; Kui F; Gao F; Niu Y; Li W; Zhang Y; Guo Z; Du G
Food Nutr Res; 2021; 65():. PubMed ID: 34908920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
